Indeus Life Sciences is a finished-dose manufacturer based in India. It appears in 3 regulatory filings across 1 regulator, without an active US DMF or CEP on file. Its GMP standing is certified by EMA. Customs aggregates show $174K of exports covering 6 molecules to 3 destinations in 2025.
| Site | FDA FEI |
|---|---|
| Mumbai, India | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| BOMRA (BW) | 3 | None |
| EMA | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2025 | Not reported | $174K | 3 |
| 2024 | Not reported | $146K | 1 |
| 2023 | Not reported | $296K | 3 |
| 2022 | Not reported | $467K | 3 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. Indeus Life Sciences comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.